A Novel Drug Repositioning Approach based on Collaborative Metric Learning.
Computational drug repositioning is an important and efficient approach to infer potential indications for drugs, and can improve the efficiency of drug development. The drug repositioning problem essentially is a top-K recommendation task that recommends most likely diseases to drugs based on drug and disease related information. Therefore, many recommendation methods can be adopted to drug repositioning. Collaborative metric learning (CML) algorithm can produce distance metrics that capture the important relationships among objects, and has been applied successfully in recommendation domains. By applying CML in drug repositioning, a joint metric space is learned to encode not only drug preferences for different diseases but also the drug-drug and disease-disease similarity, and can uncover the underlying fine-grained preferences of drugs. In this study, we propose a novel drug repositioning computational method based on Collaborative Metric Learning (CML) to predict novel drug-disease associations based on known drug and disease related information. Specifically, the proposed method learns the latent features of drugs and diseases by applying metric learning, and then predicts the association probability of one drug-disease pair based on the learned features. The comprehensive experimental results show that CMLDR outperforms the other state-of-the-art drug repositioning algorithms in terms of precision, recall, and AUPR.